Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile

about

Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile

Item

http://www.wikidata.org/entity/Q35811893

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Allogeneic hematopoietic cell ...... for adverse molecular profile

@ast

Allogeneic hematopoietic cell ...... for adverse molecular profile

@en

type

Item

label

Allogeneic hematopoietic cell ...... for adverse molecular profile

@ast

Allogeneic hematopoietic cell ...... for adverse molecular profile

@en

prefLabel

Allogeneic hematopoietic cell ...... for adverse molecular profile

@ast

Allogeneic hematopoietic cell ...... for adverse molecular profile

@en

P1476

Allogeneic hematopoietic cell ...... for adverse molecular profile

@en

P2093

Bruno C Medeiros

http://www.w3.org/2001/XMLSchema#string

David B Miklos

http://www.w3.org/2001/XMLSchema#string

Ginna G Laport

http://www.w3.org/2001/XMLSchema#string

Judith A Shizuru

http://www.w3.org/2001/XMLSchema#string

Laura J Johnston

http://www.w3.org/2001/XMLSchema#string

Lu Tian

http://www.w3.org/2001/XMLSchema#string

Mary-Elizabeth M Percival

http://www.w3.org/2001/XMLSchema#string

Robert Lowsky

http://www.w3.org/2001/XMLSchema#string

Robert S Negrin

http://www.w3.org/2001/XMLSchema#string

Sally Arai

http://www.w3.org/2001/XMLSchema#string

P2860

Indications for allogeneic hematopoietic cell transplantation for acute myeloid leukemia in the genomic era

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.

Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY

Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

P2888

bmt.2015.62

P304

1004-1006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2015.62

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275217342

http://www.w3.org/2001/XMLSchema#string

P698

25893457

http://www.w3.org/2001/XMLSchema#string

P921

karyotype

P932

4489984

http://www.w3.org/2001/XMLSchema#string